Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darvadstrocel for Complex Perianal Fistulas in Pediatric Crohn’s Disease
2023-503973-39-00Phase 3Completed
- Sponsor
- Takeda
- Start
- Jul 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 5
01
Overview
Phase 3, open-label, single-arm trial of darvadstrocel in Crohn's disease, sponsored by Takeda. Primary endpoint: Combined remission at Week 24. Started Jul 2023; status: completed.
02
Drugs
darvadstrocel
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2023-503973-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503973-39-00.